$85 Million

Clearside Biomedical

Follow-on Offering

Bookrunner, March 2018

Clearside Biomedical
Clearside BioMedical is a late-stage clinical biopharmaceutical company developing drug therapies to treat blinding diseases of the eye. Its product candidates are injected into the suprachoroidal space (SCS) using its proprietary SCS Microinjector.